ArticleBiochemistry and biophysics reports2025
Ginsenoside Rg1 alleviated testicular and sperm damage in rats exposed to bisphenol A.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol-A (BPA), a global environmental contaminant, is a well-known endocrine disruptor that can impair male reproductive function. The purpose of the study was to investigate the effects of ginsenoside Rg1 on alleviating BPA-induced testicular dysfunction and poor sperm quality. Adult male rats were divided into four groups: control, BPA, BPA + Rg1, and Rg1. Rats were injected intraperitoneally daily with BPA (50 mg/kg) and Rg1 (20 mg/kg) for 8 weeks. The histopathology of testicular tissues, sperm quality, mRNA and protein expression of Bax and Bcl-2, serum levels of testosterone, FSH, and LH, and the activity of antioxidant markers (MDA, SOD, and GPx) were determined. BPA exposure resulted in a significant reduction in the thickness and diameter of seminiferous tubules, a decrease in both mRNA and protein expression of Bax, a reduction in serum levels of testosterone, LH, and FSH, a reduction in SOD and GPx activity, and an elevation in MDA levels. Additionally, BPA exposure resulted in increased DNA fragmentation, chromatin decondensation, and abnormalities in sperm samples. All end points examined above were significantly reversed by Rg1 co-treatment, suggesting that the administration of ginsenoside Rg1 can provide protective effects against BPA-induced testicular impairments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.